Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model

Physiological Genomics

Volumn 25, Issue 2, 2006, Pages 336-345

  Haston, Christina K ^a   Cory, Sean ^b   Lafontaine, Laurie ^a   Dorion, Geneviève ^a   Hallett, Michael T ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

BALB; C57BL 6

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA METABOLISM; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MALE; MICROARRAY ANALYSIS; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CFTR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PNEUMONIA; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SPECIES SPECIFICITY; T-LYMPHOCYTES;

ANIMALIA;

EID: 33645772458     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00208.2005     Document Type: Article

References (35)

1. Cho HY, Reddy SP, Yamamoto M, and Kleeberger SR. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18: 1258-1260, 2004.
2. Davidson DJ, Webb S, Teague P, Govan JR, and Dorin JR. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load. Pathobiology 71: 152-158, 2004.
3. Davis PB, Drumm M, and Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 154: 1229-1256, 1996.
4. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, and Knowles MR; Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353: 1443-1453, 2005.
5. Durie PR, Kent G, Phillips MJ, and Ackerley CA. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol 164: 1481-1493, 2004.
6. Flint J, Valdar W, Shifman S, and Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6: 271-286, 2005.
7. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, and Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004.
8. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, and Tsui LC. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome 13: 605-613, 2002.
9. Hoyt DG and Lazo JS. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 246: 765-771, 1988.
10. Hoyt DG and Lazo JS. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-beta in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. J Pharmacol Exp Ther 249: 38-43, 1989.
11. Hubeau C, Lorenzato M, Couetil JP, Hubert D, Dusser D, Puchelle E, and Gaillard D. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 124: 69-76, 2001.
12. Ihaka R and Gentleman R. A language for data analysis and graphics. J Comput Graphic Stat 5: 299-314, 1996.
13. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, and Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15, 2003.
14. Ji B, Chen XQ, Misek DE, Kuick R, Hanash S, Ernst S, Najarian R, and Logsdon CD. Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator. Physiol Genomics 14: 59-72, 2003.
15. Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, O'Brodocvich H, Tsui LC, Buchwald M, and Tanswell AK. Lung disease in mice with cystic fibrosis. J Clin Invest 100: 3060-3069, 1997.
16. Kent G, Oliver M, Foskett JK, Frndova H, Durie P, Forstner J, Forstner GG, Riordan JR, Percy D, and Buchwald M. Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res 40: 233-241, 1996.
17. Koch C, Cuppens H, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, Navarro J, Strandvik B, and McKenzie SG; Investigators of the ERCF. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 31: 1-12, 2001.
18. Lönnstedt I and Speed TP. Replicated microarray data. Statistica Sinica 12: 31-46, 2002.
19. Ludlow LE, Johnstone RW, and Clarke CJ. The HIN-200 family: more than interferon-inducible genes? Exp Cell Res 308: 1-17, 2005.
20. Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, and Tummler B. Categories of ΔF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res 3: 277-293, 2000.
21. Merlo CA and Boyle MP. Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 141: 237-241, 2003.
22. Mickle JE and Cutting GR. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am 84: 597-607, 2000.
23. Moss RB. Lymphocytes in cystic fibrosis lung disease: a tale of two immunities. Clin Exp Immunol 135: 358-360, 2004.
24. Muhlebach MS, Stewart PW, Leigh MW, and Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160: 186-191, 1999.
25. Novak JP, Sladek R, and Hudson TJ. Characterization of variability in large-scale gene expression data: implications for study design. Genomics 79: 104-13, 2002.
26. Sadikot RT, Blackwell TS, Christman JW, and Prince AS. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171: 1209-1223, 2005.
27. Santis G, Osborne L, Knight R, Smith M, Davison T, and Hodson M. Genotype-phenotype relationship in cystic fibrosis: results from the study of monozygotic and dizygotic twins with cystic fibrosis. Pediatr Pulmonol 14: 239, 1992.
28. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3, 2004.
29. Snouwaert J, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, and Koller B. An animal model for cystic fibrosis made by gene targetting. Science 257: 1083-1088, 1992.
30. Stotland PK, Radzioch D, and Stevenson MM. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatr Pulmonol 30: 413-424, 2000.
31. Van Heeckeren AM, Schluchter MD, Drumm ML, and Davis PB. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 287: L944-L952, 2004.
32. Wayne ML and McIntyre LM. Combining mapping and arraying: an approach to candidate gene identification. Proc Natl Acad Sci USA 99: 14903-14906, 2002.
33. Winer J, Jung CK, Shackel I, and Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49, 1999.
34. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, and Whitsett JA. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278: 7674-7682, 2003.
35. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 67: 117-133, 2000.